ANAB vs AVGO · rev $234.6M vs P/E 87, rev $41.50B
AnaptysBio Inc (ANAB) versus Broadcom Inc (AVGO) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
ANAB currently screens at market cap $1.62B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Not investment advice. Open the ANAB and AVGO stock pages for the full models.
Not investment advice.